Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men

被引:80
作者
Yamada, Y
Ando, F
Niino, N
Shimokata, H
机构
[1] Gifu Int Inst Biotechnol, Dept Gene Therapy, Gifu 5040838, Japan
[2] Natl Inst Longevity Sci, Dept Epidemiol, Aichi, Japan
关键词
bone mineral density; genetics; osteoporosis; osteoprotegerin; osteoclastogenesis inhibitory factor; polymorphism;
D O I
10.1016/S1096-7192(03)00125-2
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Given that osteoprotegerin plays an important role in bone remodeling, the osteoprotegerin gene may be a candidate locus for susceptibility to osteoporosis. The relation of polymorphisms in the promoter of the osteoprotegerin gene to bone mineral density (BMD) was examined in a Japanese population-based prospective cohort study with randomly recruited subjects (1095 women and 1125 men for the 950T --> C polymorphism, 1094 women and 1127 men for the 245T --> G polymorphism). BMD at the radius was measured by peripheral quantitative computed tomography, and that for the total body, lumbar spine, right femoral neck, right trochanter, and right Ward's triangle was measured by dual-energy X-ray absorptiometry. Genotypes were determined with a fluorescence-based allele-specific DNA primer assay system. Among 950T --> C genotypes, BMD for the proximal radius was lower in premenopausal women with the CC genotype than in those with the TT or TC genotype; the difference in BMD between the two groups was 3.9% (P = 0.0075). Among 245T --> G genotypes, BMD for the radius, total body, femoral neck, trochanter, and Ward's triangle was lower in postmenopausal women with the GG genotype than in those with the TT or TG genotype, the TT genotype, or the TG genotype; the differences in BMD between the GG genotype and the TT or TG genotype were 19.8% for the distal radius (P = 0.00 15), 13.1% for the proximal radius (P = 0.0095), 11.2% for the total body (P = 0.0013), 12.9% for the femoral neck (P = 0.0067), 18.7% for the trochanter (P = 0.0008), and 27.1% for Ward's triangle (P = 0.0038). BMD was not associated with the 950T (-->) C or 245T G genotypes in men. The present results implicate the osteoprotegerin gene as a susceptibility locus for reduced BMD in Japanese women. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:344 / 349
页数:6
相关论文
共 30 条
[1]
Osteoclastogenesis inhibitory factor suppresses osteoclast survival by intetfering in the interaction of stromal cells with osteoclast [J].
Akatsu, T ;
Murakami, T ;
Nishikawa, M ;
Ono, K ;
Shinomiya, N ;
Tsuda, E ;
Mochizuki, S ;
Yamaguchi, K ;
Kinosaki, M ;
Higashio, K ;
Yamamoto, M ;
Motoyoshi, K ;
Nagata, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 250 (02) :229-234
[2]
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[3]
Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis [J].
Arko, B ;
Prezelj, J ;
Komel, R ;
Kocijancic, A ;
Hudler, P ;
Marc, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (09) :4080-4084
[4]
The effect of a single dose of osteoprotegerin in postmenopausal women [J].
Bekker, PJ ;
Holloway, D ;
Nakanishi, A ;
Arrighi, M ;
Leese, PT ;
Dunstan, CR .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (02) :348-360
[5]
A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases [J].
Body, JJ ;
Greipp, P ;
Coleman, RE ;
Facon, T ;
Geurs, F ;
Fermand, JP ;
Harousseau, JL ;
Lipton, A ;
Mariette, X ;
Williams, CD ;
Nakanishi, A ;
Holloway, D ;
Martin, SW ;
Dunstan, CR ;
Bekker, PJ .
CANCER, 2003, 97 (03) :887-892
[6]
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification [J].
Bucay, N ;
Sarosi, I ;
Dunstan, CR ;
Morony, S ;
Tarpley, J ;
Capparelli, C ;
Scully, S ;
Tan, HL ;
Xu, WL ;
Lacey, DL ;
Boyle, WJ ;
Simonet, WS .
GENES & DEVELOPMENT, 1998, 12 (09) :1260-1268
[7]
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts [J].
Burgess, TL ;
Qian, YX ;
Kaufman, S ;
Ring, BD ;
Van, G ;
Capparelli, C ;
Kelley, M ;
Hsu, HL ;
Boyle, WJ ;
Dunstan, CR ;
Hu, S ;
Lacey, DL .
JOURNAL OF CELL BIOLOGY, 1999, 145 (03) :527-538
[8]
First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q [J].
Devoto, M ;
Shimoya, K ;
Caminis, J ;
Ott, J ;
Tenenhouse, A ;
Whyte, MP ;
Sereda, L ;
Hall, S ;
Considine, E ;
Williams, CJ ;
Tromp, G ;
Kuivaniemi, H ;
Ala-Kokko, L ;
Prockop, DJ ;
Spotila, LD .
EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 (02) :151-157
[9]
TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts [J].
Fuller, K ;
Wong, B ;
Fox, S ;
Choi, YW ;
Chambers, TJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (05) :997-1001
[10]
Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts [J].
Hakeda, Y ;
Kobayashi, Y ;
Yamaguchi, K ;
Yasuda, H ;
Tsuda, E ;
Higashio, K ;
Miyata, T ;
Kumegawa, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 251 (03) :796-801